Monday, March 25, 2013

NIH Cooperative Centers on Human Immunology (U19)


Part 1. Overview Information
Number of Applications
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.855; 93.856    
Funding Opportunity Purpose
The purpose of this Funding Opportunity is to support hypothesis-testing, mechanistic studies on the activation and regulation of human immune responses in the context of infectious disease. The immediate objectives are to support research on human immunological responses to infection, vaccination against infectious disease, or administration of a vaccine adjuvant(s) that targets an innate immune receptor(s); and to support the stable, flexible, centralized infrastructure needed to promote and coordinate multi-disciplinary research in human immunology as it relates to defense against infectious disease. This research program was initiated by NIAID in fiscal year 2003 and is being renewed for the second time through open competition. All qualified investigators are invited to apply; prior funding under this program or through NIAID or NIH is not required.
Key Dates
Posted Date
March 21, 2013
Letter of Intent Due Date(s)
June 28, 2013
Application Due Date(s)
July 29, 2013
Scientific Merit Review
November, 2013
Advisory Council Review
January, 2014
Earliest Start Date
May, 2014
Required Application Instructions
It is critical that applicants follow the instructions in the PHS 398 Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. While some links are provided, applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.